LeonaBio, Inc.
LONA
$11.26
$0.262.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -7.01% | 11.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 52.41% | -5.72% | |||
| Operating Income | -52.41% | 5.72% | |||
| Income Before Tax | -1,153.80% | 5.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1,153.80% | 5.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,153.80% | 5.10% | |||
| EBIT | -52.41% | 5.72% | |||
| EBITDA | -54.34% | 5.92% | |||
| EPS Basic | -825.07% | 5.93% | |||
| Normalized Basic EPS | -65.93% | 5.93% | |||
| EPS Diluted | -825.07% | 5.93% | |||
| Normalized Diluted EPS | -65.93% | 5.93% | |||
| Average Basic Shares Outstanding | 35.53% | 0.89% | |||
| Average Diluted Shares Outstanding | 35.53% | 0.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||